New light therapy combo aims to soothe dry eyes

NCT ID NCT07239128

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested whether low-level light therapy (LLLT) plus non-steroidal immunosuppressant eye drops can help people with dry eye disease. 160 participants received three weekly light sessions along with either cyclosporine or tacrolimus drops. The goal was to see if the combination improves symptoms and tear film stability better than drops alone.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Low-level light therapy (LLLT) and topical cyclosporine A or tacrolimus

What this could lead to

If successful, this combination could offer a new, non-invasive way to manage dry eye symptoms and improve eye comfort.

What could go wrong

This is a very early (Phase 1) study with no results yet. The benefits may be small or not better than existing treatments, and light therapy devices are not widely available.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DRY EYE DISEASE (DED) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

dry eye syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Biomeeting Day Surgery center

    Reggio Calabria, Calabria, 89123, Italy

  • Centro Oculistico Borroni

    Gallarate, Varese, 21013, Italy